Parabilis Medicines Accounts Payable

Parabilis Medicines (PBLS) currently reports a accounts payable of $19M as of June 2026. Use the charts on this page to explore Parabilis Medicines's accounts payable history and peer comparisons.

Parabilis Medicines reported $19M in accounts payable as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Parabilis Medicines, and consider following PBLS for alerts when major investors trade the stock.

Parabilis Medicines is classified in the Healthcare sector. On accounts payable, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PBLS with unrelated industries.